18-Jan-17 Private equity firms and hedge funds are investing heavily into China’s healthcare industry in a bet on the sector’s upbeat growth potential. Private hospitals and drug makers are among the bright spots for investors focusing on China, where rising income and an ageing population are boosting the demand for quality medical services. [image: South China Morning Post]

24-Nov-16 Korean biotech and healthcare companies are expanding their business in Japan. Macrogen recently established in Kyoto to provide a genome analysis service. Medipost set up a JV in Japan to release its stem cell therapy product Cartistem. MediTox is supplying anti-aging products in the Japanese market and Tego Science exhibited its anti-wrinkle cell therapy product TPX-105 at Bio Japan. [image: Business Korea]

15-Nov-16 The Gwangju Institute of Science & Technology in Korea has developed a contact lens for glaucoma treatment that improves drug delivery efficiency by adding vitamin to soft contact lenses. Fat-soluble vitamin A and vitamin E lump with each other in the inside of a contact lens and form a concrete surface which absorbs and maintains more glaucoma medication. [image: Business Korea]

11-Nov-16 The Taiwan government plans to invest NTD11 bn (USD374 mn) in the biomedical industry in 2017 to develop large-scale healthcare firms, new drugs and new medical devices. The project aims to relax investment and recruitment regulations to lure and retain foreign capital and talent, and to encourage local businesses to acquire international companies and develop foreign markets. [image: CNA]

08-Nov-16 The cost of sequencing a human genome has plummeted over the past 15 years USD1,000. In Singapore, the Centre for Big Data and Integrative Genomics, part of government agency A*STAR, is supporting the Platinum Genome Project to construct reference genomes for the Chinese, Malay and Indian populations in the country. [image: Pixabay]